We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Has Strata Skin Sciences (SSKN) Outpaced Other Medical Stocks This Year?
Read MoreHide Full Article
Investors focused on the Medical space have likely heard of Strata Skin Sciences (SSKN - Free Report) , but is the stock performing well in comparison to the rest of its sector peers? One simple way to answer this question is to take a look at the year-to-date performance of SSKN and the rest of the Medical group's stocks.
Strata Skin Sciences is a member of the Medical sector. This group includes 761 individual stocks and currently holds a Zacks Sector Rank of #6. The Zacks Sector Rank considers 16 different groups, measuring the average Zacks Rank of the individual stocks within the sector to gauge the strength of each group.
The Zacks Rank is a proven system that emphasizes earnings estimates and estimate revisions, highlighting a variety of stocks that are displaying the right characteristics to beat the market over the next one to three months. SSKN is currently sporting a Zacks Rank of #1 (Strong Buy).
Over the past 90 days, the Zacks Consensus Estimate for SSKN's full-year earnings has moved 78.10% higher. This signals that analyst sentiment is improving and the stock's earnings outlook is more positive.
Our latest available data shows that SSKN has returned about 48.78% since the start of the calendar year. At the same time, Medical stocks have gained an average of 2.52%. As we can see, Strata Skin Sciences is performing better than its sector in the calendar year.
To break things down more, SSKN belongs to the Medical Info Systems industry, a group that includes 22 individual companies and currently sits at #173 in the Zacks Industry Rank. Stocks in this group have gained about 8.95% so far this year, so SSKN is performing better this group in terms of year-to-date returns.
Going forward, investors interested in Medical stocks should continue to pay close attention to SSKN as it looks to continue its solid performance.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Has Strata Skin Sciences (SSKN) Outpaced Other Medical Stocks This Year?
Investors focused on the Medical space have likely heard of Strata Skin Sciences (SSKN - Free Report) , but is the stock performing well in comparison to the rest of its sector peers? One simple way to answer this question is to take a look at the year-to-date performance of SSKN and the rest of the Medical group's stocks.
Strata Skin Sciences is a member of the Medical sector. This group includes 761 individual stocks and currently holds a Zacks Sector Rank of #6. The Zacks Sector Rank considers 16 different groups, measuring the average Zacks Rank of the individual stocks within the sector to gauge the strength of each group.
The Zacks Rank is a proven system that emphasizes earnings estimates and estimate revisions, highlighting a variety of stocks that are displaying the right characteristics to beat the market over the next one to three months. SSKN is currently sporting a Zacks Rank of #1 (Strong Buy).
Over the past 90 days, the Zacks Consensus Estimate for SSKN's full-year earnings has moved 78.10% higher. This signals that analyst sentiment is improving and the stock's earnings outlook is more positive.
Our latest available data shows that SSKN has returned about 48.78% since the start of the calendar year. At the same time, Medical stocks have gained an average of 2.52%. As we can see, Strata Skin Sciences is performing better than its sector in the calendar year.
To break things down more, SSKN belongs to the Medical Info Systems industry, a group that includes 22 individual companies and currently sits at #173 in the Zacks Industry Rank. Stocks in this group have gained about 8.95% so far this year, so SSKN is performing better this group in terms of year-to-date returns.
Going forward, investors interested in Medical stocks should continue to pay close attention to SSKN as it looks to continue its solid performance.